Pharmacokinetics Services - Global Strategic Business Report

Report
89 Pages
September 2024
Region: Global
Global Industry Analysts, Inc
ID: 5303932

The global market for Pharmacokinetics Services is estimated at US$917.4 Million in 2023 and is projected to reach US$1.4 Billion by 2030, growing at a CAGR of 6.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Small Molecules segment, which is expected to reach US$1.1 Billion by 2030 with a CAGR of 6.1%. The Large Molecules segment is also set to grow at 7.9% CAGR over the next 7 years.
Regional Analysis: Gain insights into the U.S. market, estimated at $271.9 Million in 2023, and China, forecasted to grow at an impressive 6.1% CAGR to reach $249.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Pharmacokinetics Services Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pharmacokinetics Services Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Pharmacokinetics Services Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Biologics Consulting Group, Inc., Certara L.P., Charles River Laboratories International, Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 34 Featured):

Biologics Consulting Group, Inc.
Certara L.P.
Charles River Laboratories International, Inc.
Creative Bioarray
Eurofins Scientific, Inc.
Evotec AG
Frontage Labs
GVK Biosciences Private Limited
LGC Limited
Pacific BioLabs
Parexel International Corporation
Pharmaceutical Product Development, LLC
Product Development, LLC (Jaguar Holding Company I, LLC)
SGS SA
Shanghai Medicilon Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Global Economic Update
Pharmacokinetics Services - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Pharmacokinetics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Pharmacokinetics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Pharmacokinetics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Small Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Large Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 10: World Pharmacokinetics Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 11: USA Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 12: USA Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 13: USA 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

CANADA

Table 14: Canada Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 15: Canada Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 16: Canada 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

JAPAN

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 17: Japan Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 18: Japan Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 19: Japan 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

CHINA

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 20: China Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 21: China Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 22: China 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

EUROPE

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 23: Europe Recent Past, Current & Future Analysis for Pharmacokinetics Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 24: Europe Historic Review for Pharmacokinetics Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 25: Europe 16-Year Perspective for Pharmacokinetics Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Table 26: Europe Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: Europe Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 28: Europe 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

FRANCE

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 29: France Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 30: France Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 31: France 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

GERMANY

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 32: Germany Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 33: Germany Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 34: Germany 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

ITALY

Table 35: Italy Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 36: Italy Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 37: Italy 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

UNITED KINGDOM

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 38: UK Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: UK Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 40: UK 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

REST OF EUROPE

Table 41: Rest of Europe Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 42: Rest of Europe Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 43: Rest of Europe 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

ASIA-PACIFIC

Pharmacokinetics Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 44: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: Asia-Pacific Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 46: Asia-Pacific 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

REST OF WORLD

Table 47: Rest of World Recent Past, Current & Future Analysis for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 48: Rest of World Historic Review for Pharmacokinetics Services by Drug Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 49: Rest of World 16-Year Perspective for Pharmacokinetics Services by Drug Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2014, 2024 & 2030

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Biologics Consulting Group, Inc.
Certara L.P.
Charles River Laboratories International, Inc.
Creative Bioarray
Eurofins Scientific, Inc.
Evotec AG
Frontage Labs
GVK Biosciences Private Limited
LGC Limited
Pacific BioLabs
Parexel International Corporation
Pharmaceutical Product Development, LLC
Product Development, LLC (Jaguar Holding Company I, LLC)
SGS SA
Shanghai Medicilon Inc.

Table Information

Report Attribute	Details
No. of Pages	89
Published	September 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 917.4 Million
Forecasted Market Value ( USD ) by 2030	$ 1400 Million
Compound Annual Growth Rate	6.5%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5243EUR$5,600USD£4,421GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9962EUR$10,640USD£8,399GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15730EUR$16,800USD£13,262GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 34 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global Pharmacokinetics Services Market by Type (Large Molecules Pharmacokinetics Services, Small Molecules Pharmacokinetics Services), Application (Large Enterprise, Small and Medium Enterprise) - Forecast 2024-2030

Pharmacokinetics Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use (Biotechnology & Pharmaceutical Companies) By Region, And Segment Forecasts, 2023 - 2030

Pharmacokinetics Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Type, Service Type, Therapeutic Application, and End User, and Geography

Pharmacokinetics Service Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type